Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea. (ASAP-HF)
Auto-PAP for Pulmonary Hypertension Treatment in Decompensated Heart Failure Patients With Obstructive Sleep Apnea: A Two Center Pilot Study
Sponsor: Albert Einstein Healthcare Network
Listed as NCT02963597, this NA trial focuses on Heart Failure and Hypertension, Pulmonary and remains completed. Sponsored by Albert Einstein Healthcare Network, it has been updated 13 times since 2016, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Mar 2022 — Dec 2022 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Jan 2022 — Mar 2022 [monthly]
Completed NA
-
Dec 2021 — Jan 2022 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Apr 2020 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE4 → NA
-
Dec 2018 — Apr 2020 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Dec 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Albert Einstein Healthcare Network
- Resmed Inc
For direct contact, visit the study record on ClinicalTrials.gov .